NYSE:MCKMcKesson Stock Price, Forecast & News

$160.50

+1.56 (+0.98 %)

(As of 06/2/2020 12:33 PM ET)

Add

Compare

Today's Range

$156.98

Now: $160.50▼

$161.09

50-Day Range

$129.42

MA: $140.76▼

$158.67

52-Week Range

$112.60

Now: $160.50▼

$172.18

Volume24,416 shs

Average Volume1.54 million shs

Market Capitalization$28.40 billion

P/E Ratio31.29

Dividend Yield1.03%

Beta0.85

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices. It also provides specialty pharmaceutical solutions for pharmaceutical manufacturers; and medical-surgical supply distribution, logistics, and other services to healthcare providers. In addition, the company operates retail pharmacy chains in Europe and Canada, as well as supports independent pharmacy networks within North America and Europe; and supplies integrated pharmacy management systems, automated dispensing systems, and related services to retail, outpatient, central fill, specialty, and mail order pharmacies. Further, it provides software and analytics, network solutions, and technology-enabled services. The company serves retail national accounts, including national and regional chains, food and drug combinations, mail order pharmacies, and mass merchandisers; independent retail pharmacies; and institutional healthcare providers, such as hospitals, health systems, integrated delivery networks, and long-term care providers, as well as pharmaceutical manufacturers. McKesson Corporation was founded in 1833 and is headquartered in San Francisco, California.

Beat the Market (BTM) Rank^™

2.3 Analyst's Opinion

Consensus Rating
McKesson has received a consensus rating of Buy. The company's average rating score is 2.67, and is based on 10 buy ratings, 5 hold ratings, and no sell ratings.
Price Target Upside/Downside
According to analysts' consensus price target of $170.00, McKesson has a potential upside of 6.8% from its current price of $159.13.
Amount of Analyst Coverage
McKesson has been the subject of 12 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

3.1 Community Rank

Outperform Votes
McKesson has received 865 “outperform” votes. (Add your “outperform” vote.)
Underperform Votes
McKesson has received 534 “underperform” votes. (Add your “underperform” vote.)
Community Sentiment
McKesson has received 61.83% “outperform” votes from our community.

MarketBeat's community ratings are surveys of what our community members think about McKesson and other stocks. Vote “Outperform” if you believe MCK will outperform the S&P 500 over the long term. Vote “Underperform” if you believe MCK will underperform the S&P 500 over the long term. You may vote once every thirty days.

4.2 Dividend Strength

Dividend Leadership
McKesson is a leading dividend payer. It pays a dividend yield of 1.03%, putting its dividend yield in the top 25% of dividend-paying stocks.
Dividend Growth
McKesson has been increasing its dividend for 7 years.
Dividend Coverage
The dividend payout ratio of McKesson is 10.97 %. This payout ratio is at a healthy, sustainable level, below 75%.
Dividend Sustainability
Based on earnings estimates, McKesson will have a dividend payout ratio of 9.82 % next year. This indicates that McKesson will be able to sustain or increase its dividend.

1.0 Company Ownership

Insider Buying vs. Insider Selling
In the past three months, McKesson insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $1,571,794.00 in company stock.
Percentage Held by Insiders
Only 0.88% of the stock of McKesson is held by insiders.
Percentage Held by Institutions
80.50% of the stock of McKesson is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

0.6 Earnings and Valuation

Earnings Growth
Earnings for McKesson are expected to grow by 16.30% in the coming year, from $14.36 to $16.70 per share.
Price to Earnings Ratio vs. the Market
The P/E ratio of McKesson is 31.02, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 15.69.
Price to Earnings Ratio vs. Sector
The P/E ratio of McKesson is 31.02, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 25.38.
Price to Earnings Growth Ratio
McKesson has a PEG Ratio of 1.82. PEG Ratios above 1 indicate that a company could be overvalued.
Price to Book Value per Share Ratio
McKesson has a P/B Ratio of 5.30. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Overall Beat the Market Rank^™

2.25 out of 5 stars

Industry, Sector and Symbol

Stock Exchange NYSE

Industry Drugs, proprietaries, & sundries

Sub-IndustryHealth Care Distributors

SectorMedical

Current SymbolNYSE:MCK

Previous Symbol

CUSIP58155Q10

CIK927653

Webwww.mckesson.com

Phone972-446-4800

Debt

Debt-to-Equity Ratio1.51

Current Ratio0.99

Quick Ratio0.60

Price-To-Earnings

Trailing P/E Ratio31.29

Forward P/E Ratio11.18

P/E Growth1.82

Sales & Book Value

Annual Sales$231.05 billion

Price / Sales0.12

Cash Flow$21.60 per share

Price / Cash Flow7.43

Book Value$30.01 per share

Price / Book5.35

Profitability

EPS (Most Recent Fiscal Year)$14.95

Net Income$900 million

Net Margins0.39%

Return on Equity41.07%

Return on Assets4.47%

Miscellaneous

Employees80,000

Outstanding Shares176,930,000

Market Cap$28.40 billion

Next Earnings Date7/29/2020 (Estimated)

OptionableOptionable

Receive MCK News and Ratings via Email

Sign-up to receive the latest news and ratings for MCK and its competitors with MarketBeat's FREE daily newsletter.

McKesson (NYSE:MCK) Frequently Asked Questions

How has McKesson's stock been impacted by COVID-19 (Coronavirus)?

McKesson's stock was trading at $135.17 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, MCK shares have increased by 17.7% and is now trading at $159.13. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of McKesson?

15 Wall Street analysts have issued "buy," "hold," and "sell" ratings for McKesson in the last year. There are currently 5 hold ratings and 10 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for McKesson.

When is McKesson's next earnings date?

McKesson is scheduled to release its next quarterly earnings announcement on Wednesday, July 29th 2020. View our earnings forecast for McKesson.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) posted its earnings results on Wednesday, May, 20th. The company reported $4.27 EPS for the quarter, beating the consensus estimate of $4.10 by $0.17. The business earned $58.54 billion during the quarter, compared to analyst estimates of $55.60 billion. McKesson had a net margin of 0.39% and a return on equity of 41.07%. McKesson's revenue was up 11.6% compared to the same quarter last year. During the same quarter in the prior year, the firm earned $3.69 EPS. View McKesson's earnings history.

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Wednesday, April 29th. Shareholders of record on Monday, June 1st will be paid a dividend of $0.41 per share on Wednesday, July 1st. This represents a $1.64 dividend on an annualized basis and a dividend yield of 1.03%. The ex-dividend date of this dividend is Friday, May 29th. View McKesson's dividend history.

What guidance has McKesson issued on next quarter's earnings?

McKesson issued an update on its FY21 earnings guidance on Wednesday, May, 20th. The company provided EPS guidance of $13.95-14.75 for the period, compared to the Thomson Reuters consensus estimate of $15.48. The company issued revenue guidance of +2-4% to $218.6-222.9 billion, compared to the consensus revenue estimate of $234.49 billion.

What price target have analysts set for MCK?

15 brokers have issued 12-month price targets for McKesson's stock. Their forecasts range from $146.00 to $197.00. On average, they expect McKesson's stock price to reach $170.00 in the next year. This suggests a possible upside of 6.8% from the stock's current price. View analysts' price targets for McKesson.

Has McKesson been receiving favorable news coverage?

News articles about MCK stock have trended very positive this week, according to InfoTrie. The research group identifies positive and negative press coverage by reviewing more than six thousand news and blog sources in real time. The firm ranks coverage of publicly-traded companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. McKesson earned a media sentiment score of 3.5 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an impact on the stock's share price in the next few days. View the latest news aboutMcKesson.

Are investors shorting McKesson?

McKesson saw a increase in short interest in May. As of May 15th, there was short interest totaling 3,800,000 shares, an increase of 20.6% from the April 30th total of 3,150,000 shares. Based on an average daily trading volume, of 5,200,000 shares, the days-to-cover ratio is presently 0.7 days. Approximately 2.2% of the shares of the stock are short sold. View McKesson's Current Options Chain.

Who are some of McKesson's key competitors?

Some companies that are related to McKesson include AmerisourceBergen (ABC), Cardinal Health (CAH), Henry Schein (HSIC), Patterson Companies (PDCO) and Owens & Minor (OMI). View all competitors.

What other stocks do shareholders of McKesson own?

Based on aggregate information from My MarketBeat watchlists, some companies that other McKesson investors own include Walt Disney (DIS), Gilead Sciences (GILD), CVS Health (CVS), salesforce.com (CRM), UnitedHealth Group (UNH), Johnson & Johnson (JNJ), Allergan (AGN), Bank of America (BAC), AbbVie (ABBV) and Chevron (CVX).

Who are McKesson's key executives?

McKesson's management team includes the following people:

Mr. John H. Hammergren, Chairman & CEO (Age 60)
Britt J. Vitalone, CFO & Exec. VP (Age 50)
Ms. Lori A. Schechter, Chief Compliance Officer, Exec. VP & Gen. Counsel (Age 57)
Mr. Jorge L. Figueredo, Exec. VP & Chief HR Officer (Age 58)
Mr. Bansi Nagji, Exec. VP and Chief Strategy & Bus. Devel. Officer (Age 54)

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

Who are McKesson's major shareholders?

McKesson's stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (7.10%), State Street Corp (4.32%), Massachusetts Financial Services Co. MA (3.16%), Invesco Ltd. (2.78%), Pzena Investment Management LLC (1.95%) and Geode Capital Management LLC (1.57%). Company insiders that own McKesson stock include Brian S Tyler, Brian Scott Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, N Anthony Coles and Sundeep G Reddy. View institutional ownership trends for McKesson.

Which major investors are selling McKesson stock?

MCK stock was sold by a variety of institutional investors in the last quarter, including AQR Capital Management LLC, Wellington Management Group LLP, APG Asset Management N.V., BlackRock Inc., APG Asset Management N.V., APG Asset Management N.V., AJO LP, and State Street Corp. Company insiders that have sold McKesson company stock in the last year include Brian S Tyler, Britt J Vitalone, Lori A Schechter, M Christine Jacobs, and Sundeep G Reddy. View insider buying and selling activity for McKesson.

Which major investors are buying McKesson stock?

MCK stock was bought by a variety of institutional investors in the last quarter, including JPMorgan Chase & Co., The Manufacturers Life Insurance Company , BNP Paribas Arbitrage SA, Canada Pension Plan Investment Board, Balyasny Asset Management LLC, Parametric Portfolio Associates LLC, Strs Ohio, and Massachusetts Financial Services Co. MA. View insider buying and selling activity for McKesson.

How do I buy shares of McKesson?

Shares of MCK can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is McKesson's stock price today?

One share of MCK stock can currently be purchased for approximately $159.13.

How big of a company is McKesson?

McKesson has a market capitalization of $28.15 billion and generates $231.05 billion in revenue each year. The company earns $900 million in net income (profit) each year or $14.95 on an earnings per share basis. McKesson employs 80,000 workers across the globe.

What is McKesson's official website?

The official website for McKesson is www.mckesson.com.

How can I contact McKesson?

McKesson's mailing address is 6555 STATE HWY 161, IRVING TX, 75039. The company can be reached via phone at 972-446-4800 or via email at [email protected]

This page was last updated on 6/2/2020 by MarketBeat.com Staff